03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Sector leader · Diabetes
Salil Kallianpur: no photograph is held, so the sector leader plate is shown instead.
Sector leader
Salil Kallianpur
Mumbai-based healthcare industry consultant
2
0
0
0
0
0
0
0
0
Mar 2026AprMayJuneJulyAugSeptOctNovto date
2
press citations on 1 topic since 19 Mar 2026 · last quoted 20 Mar 2026
02 Quoted on · 1 of 29 topics
Salil Kallianpur: key facts
- Kind of voice
- Sector leader
- Role
- Mumbai-based healthcare industry consultant
- Quoted on
- Diabetes
- Tracked press citations
- 2
- Most recently quoted
- 20 Mar 2026
- First quoted
- 19 Mar 2026
04 On the record · press
What Salil Kallianpur has said
By outlet · linked articles
- fiercepharma.com1
- reuters.com1
Where Salil Kallianpur has been quoted
- 01With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper genericsfiercepharma.com · 20 Mar 2026
- 02Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in Indiareuters.com · 19 Mar 2026
Verbatim
“With high demand, falling prices and multiple brands, you may see direct pharmacy purchases, distributor-level leakages, or cosmetic or lifestyle use especially in urban markets. This could lead to misuse, poor titration and unmanaged side effects and eventually regulatory tightening.”
“This could lead to misuse, poor titration and unmanaged side effects and eventually regulatory tightening.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.